mRNA_hotfix is heuristic approach to adapt a stabilized mRNA to code for a protein mutation variant substitutes mutated codons with codons that maintain low predicted degradation.
This invention involved a new methodology using novel targets, TMS stimulation and a hypnosis protocol to modulate traits and help chronic pain, addiction, and mental disorders.
Polymer electrolyte membrane (PEM) fuel cells often underperform due to high overpotentials caused by sluggish kinetics. Specifically, the Pt-catalyzed oxygen reduction reaction at the cathode renders the energy efficiency well below the thermodynamic limit.
Doctors with Stanford Medicine have developed a multi-user, mixed reality medical simulation application. Medical in-situ and simulation training centers cost millions of dollars a year to administer, with limited availability to those in remote areas or the third world.
Researchers at Stanford are advancing a new class of nonlinear optical devices that operate with significantly lower energy requirements than previous platforms.
Stanford researchers have designed and tested an electrochemical gas sensor which can detect volatile organic species in the gas phase and differentiate multiple species with a single chip.
Stanford researchers are developing an improved prophylactic against pancreatitis caused by endoscopic retrograde cholangiopancreatography (ERCP), by targeting two key inflammatory pathways.
Researchers in the Nakauchi lab at Stanford University have shown that the contribution of human donor cells to tissues and organs can be increased in an interspecies host embryo by knocking out insulin growth factor 1 receptor (Igf1r).
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.
Psoriasis is a chronic skin inflammatory disease that affects 7.5 million people in the US and accounts for $1.2 billion in annual direct medical costs.
Researchers in the Felsher Lab at Stanford University have developed PD-L1 antibody fragment-conjugated nanoparticles to improve upon existing cancer immunotherapies and extend the range of indications to solid tumors.
Researchers at Stanford have developed, for the first time, a component analysis algorithm that does not require any assumption on the data structure or data generation process to find out the important components or trends in data.